Windlas Biotech approved a Rs 47 crore share buyback at Rs 1,000 per share via tender route, with April 24 set as the record date. The buyback covers 2.23% of equity and is open exclusively to public shareholders, with promoters excluded. Shares rose approximately 2% on the announcement.

2mo ago · 1 min · Markets